This site enables you to access Novartis organized symposia presented at various congresses (virtually) from 2020

The symposia downloaded using this platform are intended as an educational resource for legitimate scientific exchange and not for promotional use.

SYMPOSIA

EADV 2023

From Past to Present: What’s next for CSU?

M. Maurer, E. Kocatürk Göncü and M. Metz

Video icon Symposia

thumb icon

Welcome & Introduction

M. Maurer
 
thumb icon

Exploring the Past: Approaches to Chronic Urticaria Care

M. Maurer
 
thumb icon

Current Guidelines in CSU Management

E. Kocatürk Göncü
 
thumb icon

What’s New in Management: Future of Personalised Medicine

M. Metz
 
thumb icon

Q&A and Panel Discussion

M. Maurer, E. Kocatürk Göncü and M. Metz
 

EAACI 2022

Chronic spontaneous urticaria: Defining the pathway to successful management

M. Maurer, E. Kocatürk and S. Savic

Slides Video icon Symposia

thumb icon

Welcome & Introduction

M. Maurer
 
thumb icon

Chronic Spontaneous Urticaria: defining the pathway to successful management
A panel discussion on overcoming roadblocks to CSU care, based on real life experiences

M. Maurer, E. Kocatürk and S. Savic
 
thumb icon

Live Q&A

M. Maurer, E. Kocatürk and S. Savic
 

EADV 2021

Targeting complete CSU control: Current state of the art and future perspectives

A. M. Giménez-Arnau, R. Saini and J. Reed

Slides Video icon Symposia

thumb icon

The patient journey in CSU: The challenges we face

A. M. Giménez-Arnau
 
thumb icon

Optimizing patient outcomes in CSU: Could new biologics help achieve this?

R. Saini
 
thumb icon

Exploring novel pathways in the journey to complete CSU control

J. Reed
 

EAACI 2021

The many faces of IgE-mediated disease – A symposia series
Complete control of CSU - mission (im)possible

M. Maurer and Z. Brzoza

Slides Video icon Symposia

thumb icon

Why do our patients fail to reach complete control?

Z. Brzoza
 
thumb icon

How can targeting IgE contribute to complete control?

M. Maurer
 

EAACI 2020

Breakthrough in the understanding of the anti-IgE pathway in CSU

M. Maurer, A. Eggel

Video icon Symposia

thumb icon

IgE inhibition in CSU: Not all anti-IgEs are born equal

A. Eggel
thumb icon

IgE inhibition implications: How does this benefit patients with chronic spontaneous urticaria?

M. Maurer

EADV 2020

Redefining patient care in chronic spontaneous urticaria

M. Maurer, A. Giménez-Arnau, A. Eggel

Video icon Symposia

thumb icon

Be AWARE: Learnings from real-world evidence

A. Giménez-Arnau
thumb icon

IgE inhibition in CSU: Not all anti-IgEs are born equal

A. Eggel
thumb icon

IgE implications: How does this benefit patients with CSU?

M. Maurer
© Copyright 2024 Novartis Pharma AG